These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 19653263

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer.
    Maher SG, Gillham CM, Duggan SP, Smyth PC, Miller N, Muldoon C, O'Byrne KJ, Sheils OM, Hollywood D, Reynolds JV.
    Ann Surg; 2009 Nov; 250(5):729-37. PubMed ID: 19801928
    [Abstract] [Full Text] [Related]

  • 44. Lymph node harvest after proctectomy for invasive rectal adenocarcinoma following neoadjuvant therapy: does the same standard apply?
    Wang H, Safar B, Wexner S, Zhao R, Cruz-Correa M, Berho M.
    Dis Colon Rectum; 2009 Apr; 52(4):549-57. PubMed ID: 19404052
    [Abstract] [Full Text] [Related]

  • 45. Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy.
    Weiss C, von Römer F, Capalbo G, Ott OJ, Wittlinger M, Krause SF, Sauer R, Rödel C, Rödel F.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1455-60. PubMed ID: 19231102
    [Abstract] [Full Text] [Related]

  • 46. Survivin expression levels as independent predictors of survival for osteosarcoma patients.
    Osaka E, Suzuki T, Osaka S, Yoshida Y, Sugita H, Asami S, Tabata K, Sugitani M, Nemoto N, Ryu J.
    J Orthop Res; 2007 Jan 01; 25(1):116-21. PubMed ID: 17034065
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer.
    Schneider PM, Metzger R, Schaefer H, Baumgarten F, Vallbohmer D, Brabender J, Wolfgarten E, Bollschweiler E, Baldus SE, Dienes HP, Hoelscher AH.
    Ann Surg; 2008 Dec 01; 248(6):902-8. PubMed ID: 19092334
    [Abstract] [Full Text] [Related]

  • 49. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
    Epari K, Cade R.
    ANZ J Surg; 2009 Apr 01; 79(4):251-7. PubMed ID: 19432710
    [Abstract] [Full Text] [Related]

  • 50. Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resection.
    Hoffmann AC, Brabender J, Metzger R, Ling F, Warnecke-Eberz U, Lurje G, Hoelscher AH, Schneider PM, Vallböhmer D.
    J Surg Oncol; 2009 Apr 01; 99(5):296-301. PubMed ID: 19180589
    [Abstract] [Full Text] [Related]

  • 51. Antibody responses to survivin and their clinical significance in patients with head and neck cancer.
    Eto M, Kodama S, Uemura N, Suzuki M.
    Head Neck; 2007 Dec 01; 29(12):1128-35. PubMed ID: 17636541
    [Abstract] [Full Text] [Related]

  • 52. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y, Mowla SJ, Ziaee SA.
    Cancer Detect Prev; 2009 Dec 01; 32(4):308-13. PubMed ID: 19186007
    [Abstract] [Full Text] [Related]

  • 53. CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer.
    Metzger R, Heukamp L, Drebber U, Bollschweiler E, Zander T, Hoelscher AH, Warnecke-Eberz U.
    Pharmacogenomics; 2010 Aug 01; 11(8):1105-13. PubMed ID: 20712528
    [Abstract] [Full Text] [Related]

  • 54. Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial.
    Brücher BL, Stein HJ, Zimmermann F, Werner M, Sarbia M, Busch R, Dittler HJ, Molls M, Fink U, Siewert JR.
    Eur J Surg Oncol; 2004 Nov 01; 30(9):963-71. PubMed ID: 15498642
    [Abstract] [Full Text] [Related]

  • 55. Multipoint quantification of multimarker genes in peripheral blood and micrometastasis characteristic in peri-operative esophageal cancer patients.
    Liu Z, Jiang M, Yan F, Xu L, Zhao J, Ju H.
    Cancer Lett; 2008 Mar 08; 261(1):46-54. PubMed ID: 18082938
    [Abstract] [Full Text] [Related]

  • 56. Role of neoadjuvant therapy for esophageal adenocarcinoma.
    Ku GY, Ilson DH.
    Surg Oncol Clin N Am; 2009 Jul 08; 18(3):533-46. PubMed ID: 19500742
    [Abstract] [Full Text] [Related]

  • 57. Response to preoperative therapy in upper gastrointestinal cancers.
    Brücher BL, Swisher SG, Königsrainer A, Zieker D, Hartmann J, Stein H, Kitagawa Y, Law S, Ajani JA.
    Ann Surg Oncol; 2009 Apr 08; 16(4):878-86. PubMed ID: 19194759
    [Abstract] [Full Text] [Related]

  • 58. [Plasma methylation-specific polymerase chain reaction as a diagnostic tool for esophageal cancer patients].
    Ikoma D, Ichikawa D, Tani N, Ikoma H, Tomita H, Sai S, Okamoto K, Kikuchi S, Fujiwara H, Ueda Y, Hagiwara A, Yamagishi H.
    Gan To Kagaku Ryoho; 2006 Nov 08; 33(12):1717-9. PubMed ID: 17212085
    [Abstract] [Full Text] [Related]

  • 59. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.
    Ren DN, Kim IY, Koh SB, Chang SJ, Eom M, Yi SY, Seong SH, Kim MD, Bronner MP, Cho MY.
    J Surg Oncol; 2009 Dec 01; 100(7):546-52. PubMed ID: 19722231
    [Abstract] [Full Text] [Related]

  • 60. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma.
    Song KY, Jung CK, Park WS, Park CH.
    Jpn J Clin Oncol; 2009 May 01; 39(5):290-6. PubMed ID: 19336448
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.